首页> 美国卫生研究院文献>ACR Open Rheumatology >A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus
【2h】

A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus

机译:一个生物标志物小组员工伴有系统性红斑狼疮妇女心血管事件的风险增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increase in cardiovascular events (CVEs) in systemic lupus erythematosus (SLE) is not fully explained by traditional risk factors. We previously identified four biomarkers (proinflammatory high‐density lipoprotein, leptin, soluble TNF‐like weak inducer of apoptosis (sTWEAK), and homocysteine) that we combined with age and diabetes to create the predictors of risk for elevated flares, damage progression, and increased cardiovascular diseasein patients with SLE (PREDICTS) risk profile. PREDICTS more accurately identified patients with SLE at risk for progression of subclinical atherosclerosis than any individual variable. We examined whether PREDICTS can also identify patients with SLE at risk for future CVEs.
机译:系统性狼疮红斑(SLE)中心血管事件(CVES)的增加尚未得到传统风险因素的完全解释。我们以前鉴定了四种生物标志物(促炎高密度脂蛋白,瘦素,可溶性TNF样弱诱导症(STWeak)和同型半胱氨酸),与年龄和糖尿病相结合,以创造凸起,损伤进展的风险的预测因子增加心血管疾病患者SLE(预测)风险概况。预测患有亚临床动脉粥样硬化的患者的更准确鉴定的SLE患者的患者比任何单独的变量都存在。我们检查了预测是否可以识别未来CVES风险的SLE的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号